Quantbot Technologies’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Buy
+22,193
New +$367K 0.01% 1062
2024
Q1
Sell
-31,227
Closed -$446K 1936
2023
Q4
$446K Buy
+31,227
New +$443K 0.03% 767
2022
Q3
Sell
-8,540
Closed -$119K 2075
2022
Q2
$119K Sell
8,540
-7,130
-46% -$102K 0.01% 1091
2022
Q1
$224K Buy
15,670
+11,154
+247% +$164K 0.02% 835
2021
Q4
$61K Buy
+4,516
New +$63.3K ﹤0.01% 981
2021
Q3
Sell
-2,871
Closed -$48K 1890
2021
Q2
$48K Sell
2,871
-26,462
-90% -$450K ﹤0.01% 1074
2021
Q1
$535K Buy
+29,333
New +$528K 0.05% 467
2019
Q3
Sell
-7,521
Closed -$133K 1563
2019
Q2
$133K Buy
+7,521
New +$137K 0.01% 692

Other funds holding TAK

Quantbot Technologies's TAK Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 22,193 shares worth $356K. The stake represents 0.01% of the portfolio and ranks #1062 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in TAK as recently as Q4 2023.

Quantbot Technologies first reported a position in TAK in Q2 2019 and has held it in 8 quarters since. The position peaked at $535K in Q1 2021. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Quantbot Technologies held 22,193 shares of Takeda Pharmaceutical worth $356K as of Q2 2026.
  • Takeda Pharmaceutical was a new Quantbot Technologies position in Q2 2026.
  • Takeda Pharmaceutical made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1062 holding.
  • Quantbot Technologies first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 8 quarters since.
  • Quantbot Technologies's Takeda Pharmaceutical position peaked at $535K in Q1 2021.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.